Question

Not recommended to use ACE-I + ARB + Aldosterone Rc blocker (spironolactone or eplerenone) due to risk of

A) Hypokalemia
B) Hyperkalemia
C) Hypertension
D) Hypotension

Answer 1

Using ACE inhibitors (ACE-I) in combination with angiotensin receptor blockers (ARBs) and aldosterone receptor blockers (spironolactone or eplerenone) is not recommended due to the risk of hyperkalemia.

Step-by-step explanation:

Angiotensin-converting enzyme inhibitors (ACE inhibitors or ACE-Is) are a class of medications commonly prescribed to treat various cardiovascular conditions. These medications work by inhibiting the activity of the angiotensin-converting enzyme, which plays a role in regulating blood pressure and fluid balance. By blocking this enzyme, ACE inhibitors help relax blood vessels, reduce blood pressure, and decrease the workload on the heart.

Using ACE inhibitors (ACE-I) in combination with angiotensin receptor blockers (ARBs) and aldosterone receptor blockers (spironolactone or eplerenone) is not recommended due to the risk of hyperkalemia, which is the excessive buildup of potassium in the blood.